Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


27.02.2017

1 A A Case Rep
1 Abdom Radiol (NY)
1 Acta Biomater
1 Am J Clin Pathol
2 Arch Pathol Lab Med
1 Biosens Bioelectron
1 BJU Int
1 Blood Coagul Fibrinolysis
1 BMJ Case Rep
1 Cancer Control
5 Cancer Cytopathol
1 Cancer Treat Rev
1 Cell Physiol Biochem
1 Cytopathology
1 Eur Arch Otorhinolaryngol
1 Eur J Cancer
1 Eur J Surg Oncol
1 Eur Urol
1 Exp Anim
1 Int J Clin Oncol
1 J Biosci
1 J Cancer Res Clin Oncol
1 J Cancer Surviv
1 J Geriatr Oncol
1 J Urol
1 Med Lett Drugs Ther
1 Mol Cancer Ther
1 Nat Rev Urol
1 Oncol Nurs Forum
1 Oncotarget
1 Sci Transl Med
1 Transplant Proc
3 Tumour Biol
1 Urol Oncol
1 Virchows Arch


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    A A Case Rep

  1. PATEL S, Hafez O, Sexton WJ, Edwards DA, et al
    Perioperative Management of a Patient With an Intrathecal Drug Delivery Device Infusing Ziconotide: A Case Report.
    A A Case Rep. 2017;8:78-80.
    PubMed     Text format     Abstract available


    Abdom Radiol (NY)

  2. XU X, Liu Y, Zhang X, Tian Q, et al
    Preoperative prediction of muscular invasiveness of bladder cancer with radiomic features on conventional MRI and its high-order derivative maps.
    Abdom Radiol (NY). 2017 Feb 20. doi: 10.1007/s00261-017-1079.
    PubMed     Text format     Abstract available


    Acta Biomater

  3. LIN T, Yuan A, Zhao X, Lian H, et al
    Self-assembled tumor-targeting hyaluronic acid nanoparticles for photothermal ablation in orthotopic bladder cancer.
    Acta Biomater. 2017 Feb 14. pii: S1742-7061(17)30126.
    PubMed     Text format     Abstract available


    Am J Clin Pathol

  4. VOLLMER RT
    A Review of Outcomes for Stage Ta Bladder Tumors.
    Am J Clin Pathol. 2016;146:215-20.
    PubMed     Text format     Abstract available


    Arch Pathol Lab Med

  5. ZHOU AG, Liu Y, Cyr MS, Garver J, et al
    Role of Tetrasomy for the Diagnosis of Urothelial Carcinoma Using UroVysion Fluorescent In Situ Hybridization.
    Arch Pathol Lab Med. 2016;140:552-9.
    PubMed     Text format     Abstract available

  6. SANFRANCESCO J, McKenney JK, Leivo MZ, Gupta S, et al
    Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition.
    Arch Pathol Lab Med. 2016;140:543-51.
    PubMed     Text format     Abstract available


    Biosens Bioelectron

  7. XU X, Wei M, Liu Y, Liu X, et al
    A simple, fast, label-free colorimetric method for detection of telomerase activity in urine by using hemin-graphene conjugates.
    Biosens Bioelectron. 2017;87:600-606.
    PubMed     Text format     Abstract available


    BJU Int

  8. VESKIMAE E, Neuzillet Y, Rouanne M, MacLennan S, et al
    Systematic review of the oncological and functional outcomes of pelvic organ-preserving cystectomy compared with standard radical cystectomy in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer.
    BJU Int. 2017 Feb 20. doi: 10.1111/bju.13819.
    PubMed     Text format     Abstract available


    Blood Coagul Fibrinolysis

  9. LOVDAHL S, Henriksson KM, Baghaei F, Holmstrom M, et al
    Malignancies in Swedish persons with haemophilia: a longitudinal registry study.
    Blood Coagul Fibrinolysis. 2016;27:631-6.
    PubMed     Text format     Abstract available


    BMJ Case Rep

  10. SMITH DM
    BCG-osis following intravesical BCG treatment leading to miliary pulmonary nodules, penile granulomas and a mycotic aortic aneurysm.
    BMJ Case Rep. 2016;2016.
    PubMed     Text format     Abstract available


    Cancer Control

  11. LIU Y, Bui MM, Xu B
    Urothelial Carcinoma With Squamous Differentiation Is Associated With High Tumor Stage and Pelvic Lymph-Node Metastasis.
    Cancer Control. 2017;24:78-82.
    PubMed     Text format     Abstract available


    Cancer Cytopathol

  12. ZHANG ML, Rosenthal DL, VandenBussche CJ
    The cytomorphological features of low-grade urothelial neoplasms vary by specimen type.
    Cancer Cytopathol. 2016;124:552-64.
    PubMed     Text format     Abstract available

  13. ROSENTHAL DL
    High apoptotic index in urine cytology is associated with high-grade urothelial carcinoma.
    Cancer Cytopathol. 2016;124:538-9.
    PubMed     Text format    

  14. BRIMO F, Auger M
    The atypical urothelial cell category in the Paris System: Strengthening the Achilles' heel.
    Cancer Cytopathol. 2016;124:305-6.
    PubMed     Text format    

  15. PHAM HV, Pantanowitz L, Liu Y
    Quantitative phase imaging to improve the diagnostic accuracy of urine cytology.
    Cancer Cytopathol. 2016;124:641-50.
    PubMed     Text format     Abstract available

  16. YANG CS, Chen S, Cramer HM, Wu HH, et al
    High apoptotic index in urine cytology is associated with high-grade urothelial carcinoma.
    Cancer Cytopathol. 2016;124:546-51.
    PubMed     Text format     Abstract available


    Cancer Treat Rev

  17. BELLMUNT J, Powles T, Vogelzang NJ
    A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now.
    Cancer Treat Rev. 2017;54:58-67.
    PubMed     Text format     Abstract available


    Cell Physiol Biochem

  18. LI P, Yang X, Cheng Y, Zhang X, et al
    MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1.
    Cell Physiol Biochem. 2017;41:921-932.
    PubMed     Text format     Abstract available


    Cytopathology

  19. COURTADE-SAIDI M, Aziza J, d'Aure D, Berard E, et al
    Immunocytochemical staining for p53 and Ki-67 helps to characterise urothelial cells in urine cytology.
    Cytopathology. 2016;27:456-464.
    PubMed     Text format     Abstract available


    Eur Arch Otorhinolaryngol

  20. VAN DE GOOR RM, Leunis N, van Hooren MR, Francisca E, et al
    Feasibility of electronic nose technology for discriminating between head and neck, bladder, and colon carcinomas.
    Eur Arch Otorhinolaryngol. 2017;274:1053-1060.
    PubMed     Text format     Abstract available


    Eur J Cancer

  21. KAWADA T
    Bladder cancer and smoking with special reference to education.
    Eur J Cancer. 2017;75:1-2.
    PubMed     Text format    


    Eur J Surg Oncol

  22. GENG J, Fan J, Wang Q, Zhang XP, et al
    Decreased REG1alpha expression suppresses growth, invasion and angiogenesis of bladder cancer.
    Eur J Surg Oncol. 2017 Feb 2. pii: S0748-7983(17)30108.
    PubMed     Text format     Abstract available


    Eur Urol

  23. MARQUES M, Real FX
    PIcKing on Fibroblast Growth Factor Receptors as Bladder Cancer Therapeutic Targets.
    Eur Urol. 2017 Feb 14. pii: S0302-2838(17)30087.
    PubMed     Text format    


    Exp Anim

  24. TEKE K, Ozkan TA, Cebeci OO, Yilmaz H, et al
    Preventive effect of intravesical ozone supplementation on n-methyl-n-nitrosourea-induced non-muscle invasive bladder cancer in male rats.
    Exp Anim. 2017 Feb 22. doi: 10.1538/expanim.16-0093.
    PubMed     Text format     Abstract available


    Int J Clin Oncol

  25. KISHIMOTO N, Takao T, Kuribayashi S, Yamamichi G, et al
    The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
    Int J Clin Oncol. 2017;22:153-158.
    PubMed     Text format     Abstract available


    J Biosci

  26. DE OLIVEIRA DT, Savio AL, Marcondes JP, Barros TM, et al
    Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status.
    J Biosci. 2017;42:91-101.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  27. TANG M, Zhao Y, Liu N, Chen E, et al
    Overexpression of HepaCAM inhibits bladder cancer cell proliferation and viability through the AKT/FoxO pathway.
    J Cancer Res Clin Oncol. 2017 Feb 22. doi: 10.1007/s00432-016-2333.
    PubMed     Text format     Abstract available


    J Cancer Surviv

  28. EDMONDSON AJ, Birtwistle JC, Catto JW, Twiddy M, et al
    The patients' experience of a bladder cancer diagnosis: a systematic review of the qualitative evidence.
    J Cancer Surviv. 2017 Feb 17. doi: 10.1007/s11764-017-0603.
    PubMed     Text format     Abstract available


    J Geriatr Oncol

  29. CANYILMAZ E, Yoney A, Serdar L, Uslu GH, et al
    Corrigendum to "Long-term results of a concomitant boost radiotherapy technique for elderly patients with muscle-invasive bladder cancer" [J Geriatr Oncol6 (4) (July 2015)316-323].
    J Geriatr Oncol. 2017 Feb 16. pii: S1879-4068(17)30026.
    PubMed     Text format    


    J Urol

  30. CHANG SS
    Re: Benefits of Adjuvant Chemotherapy for Bladder Cancer.
    J Urol. 2017;197.
    PubMed     Text format    


    Med Lett Drugs Ther


  31. Atezolizumab (Tecentriq) for bladder cancer and NSCLC.
    Med Lett Drugs Ther. 2017;59:e40-e41.
    PubMed     Text format    


    Mol Cancer Ther

  32. JIANG G, Huang C, Li J, Huang H, et al
    Role of STAT3 and FOXO1 in the divergent therapeutic responses of non-metastatic and metastatic bladder cancer cells to miR-145.
    Mol Cancer Ther. 2017 Feb 21. pii: molcanther.0631.2016.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  33. SIDAWAY P
    Bladder cancer: Mutations in DNA-damage-repair pathways confer platinum sensitivity.
    Nat Rev Urol. 2017 Feb 14. doi: 10.1038/nrurol.2017.
    PubMed     Text format    


    Oncol Nurs Forum

  34. POZZAR RA, Berry DL
    Gender Differences in Bladder Cancer Treatment Decision Making.
    Oncol Nurs Forum. 2017;44:204-209.
    PubMed     Text format     Abstract available


    Oncotarget

  35. INGELMO-TORRES M, Lozano JJ, Izquierdo L, Carrion A, et al
    Urinary cell microRNA-based prognostic classifier for non-muscle invasive bladder cancer.
    Oncotarget. 2017 Feb 14. doi: 10.18632/oncotarget.15315.
    PubMed     Text format     Abstract available


    Sci Transl Med

  36. LER LD, Ghosh S, Chai X, Thike AA, et al
    Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2.
    Sci Transl Med. 2017;9.
    PubMed     Text format     Abstract available


    Transplant Proc

  37. DEMIRDAG C, Citgez S, Talat Z, Onal B, et al
    Management of Bladder Cancer After Renal Transplantation.
    Transplant Proc. 2017;49:293-296.
    PubMed     Text format     Abstract available


    Tumour Biol

  38. ZHI Y, Ji H, Pan J, He P, et al
    Downregulated XPA promotes carcinogenesis of bladder cancer via impairment of DNA repair.
    Tumour Biol. 2017;39:1010428317691679.
    PubMed     Text format     Abstract available

  39. GUO J, Cao R, Yu X, Xiao Z, et al
    MicroRNA-223-3p inhibits human bladder cancer cell migration and invasion.
    Tumour Biol. 2017;39:1010428317691678.
    PubMed     Text format     Abstract available

  40. EL-ASHMAWY NE, Khedr EG, El-Bahrawy HA, Al-Tantawy SM, et al
    Chemopreventive effect of omega-3 polyunsaturated fatty acids and atorvastatin in rats with bladder cancer.
    Tumour Biol. 2017;39:1010428317692254.
    PubMed     Text format     Abstract available


    Urol Oncol

  41. ABUFARAJ M, Shariat SF, Haitel A, Moschini M, et al
    Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancer.
    Urol Oncol. 2017 Feb 14. pii: S1078-1439(17)30014.
    PubMed     Text format     Abstract available


    Virchows Arch

  42. NGUYEN D, Taheri D, Springer S, Cowan M, et al
    High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.
    Virchows Arch. 2016;469:427-34.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: